SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is trending due to significant technical breakouts and a surge in bullish sentiment, with community discussion centered on potential S&P 500 inclusion and upcoming earnings. Investors are anticipating long-term growth catalysts, including CEO Noto's performance-based share targets and the company's strong position within the evolving fintech landscape. Despite previous discussions around share offerings, the focus remains on SoFi's overall trajectory and expanding ecosystem.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences (SLS) is experiencing intense bullish momentum and community discussion, largely driven by its sustained trading above the critical $5 threshold, which opens the door for institutional investment. Investors are keenly focused on the anticipated potential of its GPS immunotherapy to revolutionize AML treatment through extended patient survival, fueling expectations for a substantial revaluation or potential buyout. This positive sentiment, amplified by high borrow fees and limited short availability, is generating significant short and gamma squeeze speculation among traders.

Aeva Technologies, Inc. develops sensing paradigm for autonomous vehicles and robotics. The firm offers drones, robotics, vehicle technology, and virtual and augmented reality products. The company was founded by Soroush Salehian Dardashti and Mina Rezk in 2017 and is headquartered in Mountain View, CA.

Aeva Technologies Inc

Aeva Technologies is generating significant buzz after announcing its 4D LiDAR technology will be integrated into the NVIDIA DRIVE Hyperion platform, aiming for Level 4 self-driving capabilities. This major validation from an industry leader has ignited widespread community discussion about AEVA's strong potential in the autonomous vehicle sector, with many anticipating a significant impact due to its low float and the strategic partnership.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is experiencing strong bullish momentum, with community sentiment driven by significant ETF inflows and institutional accumulation. Many are actively discussing its perceived decoupling from Bitcoin and its potential as a utility-focused asset in the evolving global financial landscape.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is trending following its strategic collaboration with OpenAI, integrating advanced AI models into its Athena marketing platform. This partnership has ignited significant community excitement, with many viewing the company as an undervalued breakout candidate poised for substantial growth amidst increasing AI adoption in enterprise marketing.

Sailana Inu, the sister of legendary Saitama Inu, is bringing back the Wolfpack and OG community vibes that previously sent Saitama to a $7 billion marketcap in 2021. The power of community mixed with great leadership is what will take this project to great heights. Join the movement, join the pack, become apart of the Sailana Army . Together, we will create something that will go down in history, and something that will be talked about years from now.

Sailana Inu

Sailana Crypto ($SAILANA) is garnering significant attention with its actively discussed WolfSWAP, a cross-chain swap aggregator that promotes fee-sharing for other tokens, which the community hails as a pivotal step towards decentralization. The dedicated "Wolfpack" community is highly bullish, emphasizing continuous building, organic growth, and anticipating a groundbreaking flagship utility. Many believers compare its current trajectory to the early days of successful memecoins, underscoring its potential and strong community conviction.

Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA.

Alumis Inc.

Alumis Inc. is trending following highly positive topline Phase 3 results for its oral TYK2 inhibitor, envudeucitinib, in moderate-to-severe plaque psoriasis, which demonstrated strong efficacy and met all primary and secondary endpoints. The biopharmaceutical company's robust data is fueling community excitement over its potential as a best-in-class oral therapy for immune-mediated diseases, with discussions also weighing its competitive landscape and future valuation.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is trending following a Morgan Stanley upgrade that underscores its pivotal role in establishing a U.S. domestic rare earth supply chain. Community discussions focus on the company's strategic government and Apple partnerships, which provide significant long-term tailwinds. This comes as geopolitical dynamics continue to emphasize the critical need for non-Chinese sources for essential materials in defense and technology.

Bright Minds Biosciences, Inc. is a biotechnology company, which engages in the development of therapeutics. The company was founded by Ian B. McDonald and Alan P. Kozikowski on May 31, 2019 and is headquartered in Chicago, IL.

Bright Minds Biosciences Inc

Bright Minds Biosciences (DRUG) is trending as investors discuss the company's targeted CNS therapies and pipeline focus. Community members are sharing bullish charts and comparing the stock's potential to past high runners, while others are expressing regret for previous missed opportunities. The discussion includes potential catalysts, the ticker's name, and the broader biopharmaceutical sector context.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain and as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin ($XCN) is trending due to its recent listing on Robinhood, a development widely interpreted by the community as a significant boost to legitimacy and retail accessibility. This catalyst, alongside anticipation for the upcoming Goliath Mainnet focused on institutional financial infrastructure, is driving strong bullish sentiment. Many long-term holders are actively accumulating, citing increased trading volume and short covering as key factors fueling renewed optimism.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
